ImmuCell Corporation (ICCC) vs Vivani Medical, Inc. (VANI)
- ImmuCell Corporation ICCC 9.90 −0.50%
- Vivani Medical, Inc. VANI 1.06 +1.92%
ImmuCell Corporation and Vivani Medical, Inc. are both Biotechnology companies. ImmuCell Corporation and Vivani Medical, Inc. are of similar size ($93.8M and $90.4M). Vivani Medical, Inc. has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 117×. ImmuCell Corporation grew revenue faster over the last twelve months: 8.49% against −51.0%. ImmuCell Corporation has the higher net margin (2.57% vs 0.00%) and the higher return on invested capital (7.84% vs 0.00%). Across the 18 metrics below, ImmuCell Corporation leads on 16 and Vivani Medical, Inc. on 2.
Valuation
Profitability
| Metric | ICCC | VANI | Biotechnology median |
|---|---|---|---|
| Gross margin | 40.32% | 0.00% | 68.51% |
| Operating margin | 12.60% | 0.00% | 0.00% |
| Net margin | 2.57% | 0.00% | 0.00% |
| Free cash flow margin | 13.79% | 0.00% | 0.00% |
| Return on equity | 2.57% | (220.40%) | (51.96%) |
| Return on assets | 1.69% | (74.60%) | (46.06%) |
| Return on invested capital | 7.84% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack